Dbx
Payments companies reported to CMS as associated with Dbx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dbx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dbx
These are the largest totals companies reported as associated with Dbx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Dumonski | Greensboro, NC | Orthopaedic Surgery | $118.66 |
| Jeffrey Jenkins | Greensboro, NC | Neurological Surgery | $118.66 |
| Neelesh Nundkumar | Greensboro, NC | Neurological Surgery | $118.66 |
| Michael Moore | Greensboro, NC | Orthopaedic Surgery of The Spine | $118.66 |
| Charles Yu | New Orleans, LA | Orthopaedic Surgery of The Spine | $27.67 |
| Roboan Guillen Arguello | New Orleans, LA | General Practice | $27.67 |
| Gabriel Tender | New Orleans, LA | Neurological Surgery | $27.67 |
| Jeffrey Pinto | Lacombe, LA | Orthopaedic Surgery | $27.67 |
| Matthew Simonich | Pueblo, CO | Orthopaedic Surgery | $16.52 |
| Damian Gradisar | Pueblo, CO | Acute Care (Nurse Practitioner) | $16.52 |
Prescribed Dbx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.